India’s First Dengue Vaccine QDENGA to Reach Market in 2027
Published · Updated
AI-generated summary of the coverage listed below: Takeda’s dengue vaccine QDENGA, the first approved in India, is set to enter the private market in the first half of 2027 after Dr Reddy’s Laboratories signed a distribution agreement with the Japanese company. The launch will provide a new preventive option for a disease that causes thousands of hospitalisations each year across the country. The partnership aims to make the vaccine widely available nationwide.
Covered by 2 outlets across the spectrum: 0% left, 0% center, 100% right.
Who is covering this story
- Right-leaning (2): Sunday Guardian, Times of India
Sources
- India’s First Dengue Vaccine QDENGA to Launch in 2027 After Takeda-Dr Reddy’s Distribution Deal — Sunday Guardian (right-leaning)
- Dengue vaccine to hit market by first half of 2027 — Times of India (right-leaning)